• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: WILLIAM COOK EUROPE ZENITH TX2 TAA ENDOVASCULAR GRAFT PROXIMAL EXTENSION; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

WILLIAM COOK EUROPE ZENITH TX2 TAA ENDOVASCULAR GRAFT PROXIMAL EXTENSION; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number TBE-42-81-PF
Device Problems Device Damaged Prior to Use (2284); Failure to Advance (2524)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/04/2013
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Similar to device under 510(k) p070016.Summary of investigational findings: unfortunately due to the limited information provided it has not been possible to conclude an exact root cause for this event.However nothing indicates that the device was defective.Furthermore, the package insert states under users precautions - "if the packaging has been opened prior to use, or there is damage or contamination, and if abnormalities such as damage to the component can be seen, do not use the device." cook medical will continue to monitor for similar events.
 
Event Description
Description of event according to initial reporter: the devices were used for treatment of aortic dissection by an advising doctor's instruction though it was off-label use.Ax - ax bypass was performed and the procedure was conducted with zteg-2p-36-152-pf (distal site) + zteg-2pt-42-158-pf (proximal site), approached from the right femoral artery.Since confirmatory angiography confirmed proximal type i endolak near zteg-2pt-42-158-pf, the physician decided to place tbe-42-81-pf as an additional treatment ((b)(4)).Preparation for tbe-42-81-pf placement was made as usual, and the delivery system was inserted from the right femoral artery.However because it would not advance, the physician checked the tip of the delivery system and noticed that the sheath was curled up.He decided not to use the device to avoid damaging vascular wall with the curled part that could produce another dissection ((b)(4)).Type i endoleak was considerably reduced by re-ballooning.Therefore, no more additional treatment was performed and the physician decided to take a wait-and-see approach ((b)(4)).Patient outcome: there has been no adverse effects reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZENITH TX2 TAA ENDOVASCULAR GRAFT PROXIMAL EXTENSION
Type of Device
MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
WILLIAM COOK EUROPE
4632 bjaeverskov
DA 
Manufacturer Contact
marianne hoey
sandet 6
bjaeverskov 4632
DA   4632
56868686
MDR Report Key6334890
MDR Text Key67544442
Report Number3002808486-2017-00477
Device Sequence Number1
Product Code MIH
UDI-Device Identifier10827002526560
UDI-Public(01)10827002526560(17)150824(10)E2966910
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,o
Reporter Occupation Physician
Type of Report Initial
Report Date 01/04/2013
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/16/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberTBE-42-81-PF
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/04/2013
Date Device Manufactured08/24/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-